IDH2 and cancer: Although loss-of-function mutations of TET1/2 are less frequently found in glioma [59], the presence of D-2-HG in IDH mutated cancer is sufficient to block the activity of TETs, which results in genome-wide DNA hypermethylation [36,60,61].